COMMONWEALTH OF AUSTRALIA

Department of Health and Aged Care
Therapeutic Goods Administration

THERAPEUTIC GOODS ACT 1989

PUBLICATION OF LIST OF MANUFACTURERS REVOKED FROM LICENSING FOR

THE MANUFACTURE OF THERAPEUTIC GOODS – 8 September 2023

I, Katherine Clark, Delegate of the Secretary of the Department of Health and Aged Care, Therapeutic Goods Administration, for the purpose of Section 41 of the Therapeutic Goods Act 1989, hereby publish the following details concerning the revocation of a Licence to Manufacture Therapeutic Goods:

Under Section 41(1)(d) of the Therapeutic Goods Act 1989 the Secretary by notice in writing has revoked the Licence held by:

GlaxoSmithKline Australia Pty Ltd – lICENCE NO. mi-2015082005-li-000773-2 OF 1061 Mountain Highway Boronia VIC 3155 – AT THE REQUEST OF THE MANUFACTURER.

AROVELLA THERAPEUTICS LTD – LICENCE NO. MI-2017-LI-13480-1 OF LEVEL 1 UNIT 12/55 HOWE STREET OSBORNE PARK WA 6017 – AT THE REQUEST OF THE MANUFACTURER.

Lavida Pharmaceuticals – LICENCE NO. mi-2014-li-09274-1 OF 15 Sleigh Place Wetherill Park NSW 2164 – AT THE REQUEST OF THE MANUFACTURER.

FRESENIUS KABI AUSTRALIA PTY LTD – LICENCE NO. MI-02122005-LI-001035-11 OF 51 SARAH ANDREWS CLOSE, ERSKINE PARK NSW 2759 – AT THE REQUEST OF THE MANUFACTURER.

WA Hospitals Central Pharmaceutical Manufacturing Facility T/A AUSPMAN – LICENCE NO. MI-2015-LI-11091-1 OF Sir Charles Gairdner Hospital Pharmacy Department
Ground Floor A Block Hospital Avenue Nedlands WA 6009 – AT THE REQUEST OF THE MANUFACTURER.

Signed by

Katherine Clark

Manufacturing Quality Branch

Delegate of the Secretary

8 September 2023